Results Healthcare   |   Results International

Insights

We add value by understanding our sectors inside out, and release regular industry research and reports

AstraZeneca divested their Avlon API manufacturing site to Avara

By Kevin Bottomley 05 Dec 2016

NORWALK, C. PR NEWSWIRE DECEMBER 5, 2016

Thursday, December 1st, 2016 was an important day for the 210 people employed to produce life-saving medicines at Avlon near Bristol, UK as they joined Avara Pharmaceutical Services upon the completion of the acquisition from AstraZeneca.

Previously owned by AstraZeneca, the site was earmarked for closure due to the changing market dynamics of the pharmaceutical industry.

Tim Tyson, a global leader in the pharmaceutical industry, is Chairman and CEO of Avara Pharmaceutical Services. In his 35-plus year career, Mr. Tyson has negotiated complex multi-billion dollar mergers and acquisitions, led major turn-arounds that have fueled growth and value and, most significantly, has been instrumental in bringing more than 50 lifesaving and life improving medicines to the market.

Tim Tyson, a global leader in the pharmaceutical industry, is Chairman and CEO of Avara Pharmaceutical Services. In his 35-plus year career, Mr. Tyson has negotiated complex multi-billion dollar mergers and acquisitions, led major turn-arounds that have fueled growth and value and, most significantly, has been instrumental in bringing more than 50 lifesaving and life improving medicines to the market.

Avara has four other sites and has ambitious plans to continue to expand its network around the world. At Avlon they plan to invest and develop the business to serve the rapidly growing contract pharmaceutical manufacturing demands, ending five years of uncertainty for employees.

Avara’s Chairman and Chief Executive Officer Tim Tyson said:

“The team at Avlon are experienced and talented pharmaceutical manufacturing professionals who operate a high quality facility. We are delighted to be able to acquire this world class capability and to transition this AstraZeneca center of excellence into an international pharmaceutical services center of world-wide excellence. We have confidence in transitioning Avlon into the Avara network rapidly and building a long term, profitable growth business at this site.”

Marc Jones, Executive Vice President Europe at AstraZeneca added:

“I’d like to wholeheartedly thank the team at Avlon for their hard work and dedication even when they faced the closure of their site. I wish them and Avara every success in the future.”

 

To discover how Results Healthcare can work with you, please contact Kevin Bottomley.

Kevin Bottomley

Partner

Contact Kevin

Insights

Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office